Altimmune, Inc.
USD2.87
-0.03 (-1.03%)
CEO
Jerome Benedict Durso
IPO Date
2017-05-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.93
Prev. Close
$2.90
Day Low
$2.84
Day High
$2.95
52W Low
$2.56
52W High
$7.73
Market Cap
$0.25B
Volume
3.02M
| 48,800 |
| $2.82 |
| 1 May 2026 | Jorkasky Diane | director | A-Award | Acquired | 48,800 | $2.82 |
| 1 May 2026 | Schafer Klaus | director | A-Award | Acquired | 48,800 | $2.82 |
| 1 May 2026 | Pisano Wayne | director | A-Award | Acquired | 48,800 | $2.82 |
| 1 May 2026 | Hodges Philip | director | A-Award | Acquired | 48,800 | $2.82 |
| 1 May 2026 | GILL JOHN | director | A-Award | Acquired | 48,800 | $2.82 |
| 1 May 2026 | SAYARE MITCHEL | director | A-Award | Acquired | 48,800 | $2.82 |
| 6 Apr 2026 | GILL JOHN | director | P-Purchase | Acquired | 9,200 | $3.41 |
| 1 Apr 2026 | WEAVER GREGORY L | Chief Financial Officer | P-Purchase | Acquired | 10,000 | $3.15 |